No Data
No Data
RECBIO-B: 2024 Interim Report
Jiangsu Recbio Technology Co., Ltd. (HKG:2179) Surges 12%; Individual Investors Who Own 24% Shares Profited Along With Institutions
Express News | Jiangsu Recbio Technology - Hy Loss Attributable RMB247.7 Mln Vs Loss RMB269.1 Mln
Express News | Jiangsu Recbio Technology H1 Capex RMB 78.1 Million
RECBIO-B: UNAUDITED INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
Ruikang Biologicals (02179.HK) plans to hold a board of directors meeting on August 20 to approve its interim performance.
Ruikang Biology-B (02179.HK) announced on August 8th that the board of directors will hold a meeting on Tuesday, August 20, 2024 to review and approve the unaudited mid-year performance of the company and its subsidiaries as of June 30, 2024 and consider the distribution of interim dividends (if any).
No Data
No Data
whqqq : Will they fall after a pandemic?
Spinee OP whqqq : It's hard to say
whqqq Spinee OP : But it can still be held for a short time, right?